Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
504.2 INR | +0.79% | +1.85% | +3.06% |
Mar. 29 | Aarti Drugs Limited Announces Executive Cessation | CI |
Jan. 31 | Aarti Drugs Begins Manufacturing Dermatology Products in Tarapur, India Facility | MT |
Sales 2024 * | 26.12B 313M | Sales 2025 * | 29.48B 354M | Capitalization | 46.31B 555M |
---|---|---|---|---|---|
Net income 2024 * | 1.73B 20.75M | Net income 2025 * | 2.52B 30.16M | EV / Sales 2024 * | 1.77 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.57 x |
P/E ratio 2024 * |
26.9
x | P/E ratio 2025 * |
18.5
x | Employees | 1,003 |
Yield 2024 * |
0.93% | Yield 2025 * |
1.35% | Free-Float | 36.93% |
Latest transcript on Aarti Drugs Limited
1 day | +0.79% | ||
1 week | +1.85% | ||
Current month | +16.08% | ||
1 month | +13.75% | ||
3 months | -0.08% | ||
6 months | +5.42% | ||
Current year | +3.06% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 76 | 85-01-04 | |
Adhish P. Patil
DFI | Director of Finance/CFO | 41 | 12-07-05 |
Rushikesh Deole
CMP | Compliance Officer | - | 19-04-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 76 | 85-01-04 | |
Director/Board Member | 61 | 87-01-01 | |
Director/Board Member | 60 | 95-09-14 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 504.2 | +0.79% | 73,241 |
24-04-25 | 500.2 | -0.11% | 68,793 |
24-04-24 | 500.8 | +0.18% | 76,028 |
24-04-23 | 499.8 | +1.32% | 360,824 |
24-04-22 | 493.4 | -0.33% | 72,115 |
Delayed Quote NSE India S.E., April 26, 2024 at 07:43 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+25.83% | 653B | |
+27.00% | 556B | |
-6.76% | 354B | |
+20.34% | 331B | |
+3.00% | 296B | |
+13.09% | 233B | |
+5.46% | 201B | |
-9.61% | 193B | |
-6.26% | 144B |
- Stock Market
- Equities
- 524348 Stock
- AARTIDRUGS Stock